Today’s AI Top Pick: CSV

10/1/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Low Float Bullish Consensus Deep RotationCSVBUY NOW12.5 / 1010/1/2026

Carriage Services (CSV) is the best buy right now because it uniquely combines the strongest fundamental profile in the pool with clean multi-timeframe bullish confirmation and a fresh, positive catalyst cluster. The technical tape shows full agreement across all four timeframes: forecast fc_long_pct of 31.3% on the daily and 27.05% on the weekly confirm sustained upward momentum, while the stock sits at only 20.06% of its 21-bar daily range and 5.26% of its weekly range — meaning it is NOT chasing a top, it's coiled near the lows with room to run. Bullish probability is a full 1.0, and the daily drawdown of just -8.11% is a shallow, healthy pullback rather than a breakdown. Fundamentally, CSV is a bargain: P/E of 11.15, a forward P/E of just 8.57, PEG of 1.18, ROE of 17.13%, and an operating margin of 23.38% — all with a strong analyst consensus recommendation of 1.2 (near strong-buy) and 66.2% target upside. The news flow seals the case: on 2026-09-30 the company announced a new $300 million credit facility expanding liquidity and strategic flexibility, plus a capital allocation framework — both bullish structural signals. This is a deep-rotation value name that has been beaten down (YTD -26.31%, year -30.02%) but has stabilized technically and gained institutional support, making today's levels an ideal accumulation zone rather than a late entry. The reason CSV beats AZO and MORN on conviction is execution risk on the tape. AZO has a stronger fundamental_score (6.75) and a 1.0 bullish probability, but its weekly timeframe shows pos_in_21bar_range_pct of 0 with a -16.92% drawdown — it's sitting at the very bottom of a 21-week range after a -14.79% weekly drop, which is a weaker, more uncertain structure than CSV's coiled daily/weekly setup. MORN has the best fundamental_score in the pool (7.25) with a PEG of just 0.73 and ROE of 31.96%, but its near_term_bullish is only 0.4 and its daily forecast is negative (fc_long_pct 7.32% but recent_21bar_pct -9.42%), signaling a stock still working through a pullback. CSV is the only name where fundamentals, multi-timeframe momentum, low-range positioning, and a positive news catalyst all align simultaneously. Today is the right entry because CSV has completed its drawdown and is showing early-stage reversal confirmation rather than continuation of weakness. The shallow -8.11% daily drawdown combined with a 31.3% long-horizon forecast suggests the selling pressure has exhausted and institutions are re-engaging. Waiting risks paying a higher price if the $300M facility and capital allocation framework trigger a re-rating, especially given the 66.2% target upside and forward P/E below 9. The risk/reward is heavily skewed to the upside with a well-defined stop below the recent low.

Entry zone

Buy between $30.50 and $31.50 (current $31.17), accumulating on any dip toward the 21-bar range low near $30.50

Stop loss

Hard stop at $28.75 (below the -28.52% weekly drawdown low and psychological $29 support)

First target

$34.50 (near-term re-rating toward the 21-bar high and recent resistance)

Longer target

$40.00+ (swing target approaching analyst target price implied by 66.2% upside)

Risks

Deep-rotation name with YTD performance of -26.31% and year-over-year -30.02% indicates the downtrend may not be fully reversed despite technical confirmation
Debt-to-equity of 1.97 is elevated for a funeral services company, exposing the balance sheet to higher interest rate environments
Short float of 4.12% is modest but not negligible — a sudden short squeeze reversal could add volatility
Consumer cyclical sector exposure means revenue could remain pressured if consumer spending weakens, though sales YoY of 1.33% shows marginal stability
Fundamental_score of 6.75 is strong but CSV still trades in a value/trap territory per some analyst commentary (StockStory flagged questionable fundamentals)

Honorable mentions

AZOSecond pick with fundamental_score 6.75 and 1.0 bullish probability, but the weekly timeframe shows pos_in_21bar_range_pct of 0 with a -16.92% drawdown, indicating a weaker, more uncertain bottom-finding structure than CSV. Strong fundamentals (forward P/E 14.78, PEG 1.23) and Bernstein Outperform rating are positive, but the tape needs clearer confirmation before committing.

MORNThird pick with the best fundamental_score in the pool (7.25), PEG of 0.73, and ROE of 31.96%, plus a $5M community investment and HQ relocation as positive catalysts. However, near_term_bullish is only 0.4 and the daily timeframe shows negative momentum (recent_21bar_pct -9.42%), making this a BUY_PULLBACK rather than a BUY_NOW until the tape confirms a stable base.

Full ranking (29)

#	Symbol	Verdict	Score	Read
1	AZO	BUY PULLBACK	14.2	Strong fundamentals and Bernstein Outperform but weekly tape shows 0% range position with -16.92% drawdown — wait for clearer bottom confirmation.
2	MORN	BUY PULLBACK	13.0	Best fundamental_score (7.25) with PEG 0.73 and ROE 31.96% but near_term_bullish only 0.4 and daily momentum negative — wait for stabilization.
3	CSV	BUY NOW	12.5	Only name with full multi-timeframe bullish agreement, low-range coiled position, shallow -8.11% drawdown, forward P/E 8.57, and positive $300M facility catalyst.
4	GPI	BUY PULLBACK	11.5	Cheap at P/E 10.02 with forward P/E 5.48 and Citigroup Buy, but daily range position of 0.08% and -20.04% drawdown signal ongoing weakness.
5	ABG	BUY PULLBACK	11.0	Value at P/E 6.44 with Seaport Buy and $300 target, but multiple timeframes show 0% range position with deep drawdowns — not yet confirmed.
6	RH	WAIT	10.5	Strong ROE 280.72% but Stifel lowered target to $120 and director sold shares — technicals weak with 0% range position on both timeframes.
7	CDNL	WAIT	10.0	Strong revenue growth (sales YoY 89.75%) and Truist Buy rating but bullish_prob is null and only daily timeframe available — insufficient confirmation.
8	KAI	BUY PULLBACK	9.8	Quality industrial with 13-year CEO succession catalyst but all timeframes show 0% range position with drawdowns — wait for base formation.
9	TPB	BUY PULLBACK	9.5	SeekingAlpha upgrade says market overly concerned but only 4h timeframe available with 0% range position and -33.81% drawdown — needs more confirmation.
10	NXXT	WAIT	9.0	Explosive recent_21bar_pct of 309.22% on daily but negative margins (-62.16%) and near_term_bullish only 0.6 — speculative, wait for fundamentals to improve.
11	AKTX	BUY PULLBACK	8.8	Moderate Buy consensus and PH1 ADC platform catalyst but extreme fc_short_pct of 135.72% on 4h signals high volatility and uncertainty.
12	ENLV	WAIT	8.5	Hammer pattern and RSI 15.91 suggest oversold bounce potential but near_term_bullish only 0.8 and -95% YTD performance shows severe weakness.
13	NXTC	WAIT	8.0	High forecast magnitude (fc_long 157.27% weekly) but negative ROE -195.22% and -64.69% YTD performance — speculative, wait for profitability.
14	GRCE	WAIT	7.5	near_term_bullish only 0.4 with negative ROE -36.19% — insufficient bullish confirmation despite conference catalyst.
15	OXBR	BUY PULLBACK	7.0	Short interest fell 50.2% (positive) but negative epsNextY -225 and -10.85% operating margin — wait for earnings improvement.
16	CVM	WAIT	6.5	near_term_bullish 0 but RSI 75.68 overbought and negative ROE -252.53% — overextended, wait for pullback.
17	NAMM	WAIT	6.0	bullish_prob null with only 2 timeframes and -46.39% 4h drawdown — insufficient confirmation, await H2 results.
18	MMA	BUY PULLBACK	5.5	Cost reductions to $2.51M and pre-sale catalyst are positive but negative epsNextY and -64.55% YTD performance — speculative recovery play.
19	XTLB	WAIT	5.0	near_term_bullish only 0.4 with negative margins and -50.85% year performance — insufficient confirmation.
20	QNTM	WAIT	4.5	FDA green light for Lucid-MS Phase 2 is a strong catalyst but near_term_bullish 0 and negative ROE -429.58% — binary event risk.
21	TVRD	WAIT	4.0	Positive STAT3 preclinical data but -70.93% YTD performance and extreme drawdowns across all timeframes — high risk.
22	BCDA	WAIT	3.5	FDA submission catalyst for Shonin is positive but near_term_bullish only 0.6 and -19.2% YTD performance — wait for regulatory clarity.
23	TNXP	BUY PULLBACK	3.0	Second Medicare payer agreement for TONMYA is a strong catalyst but extreme fc_short_pct of 16047.14% on weekly signals extreme volatility.
24	SHOE	WAIT	2.5	Dividend declaration and localized store strategy are positive but -38.48% YTD performance and thin margins (2.2%) — wait for stabilization.
25	CLNN	WAIT	2.0	Moderate Buy consensus but negative ROE and -30.49% YTD performance with mixed technicals — insufficient confirmation.
26	IPWR	WAIT	1.5	near_term_bullish 0.6 but negative margins and -39282.85% profit margin signals distress — wait for profitability.
27	LEU	BUY PULLBACK	1.0	Rating upgrades and nuclear pick-and-shovel narrative are positive but -55.01% YTD performance and P/E 63.64 stretched — wait for base.
28	ANNA	WAIT	0.5	Strong sales YoY growth 554.95% and 19.76% profit margin but bullish_prob null and only 3 timeframes with -24.86% weekly drawdown — insufficient confirmation.
29	HXHX	AVOID	0.0	bullish_prob null with only 2 timeframes and -32.38% YTD performance — broken setup, avoid.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord